The Searle Company has concluded an exclusive licensing and supply agreement with Livzon Mapharm Inc. for the recombinant novel coronavirus vaccine (V-01). The licencing agreement also covers the manufacturing transition of (V-01) in Pakistan.
#RepublicNews #CovidVaccinne #SearlePharma
